Statement of Principles concerning asthma (Balance of Probabilities) (No. 32 of 2021)

The instrument operates through a small set of interlocking legal and medical concepts, each defined in the Schedule. Primary concepts are asthma and death from asthma, the factors that must exist to link asthma to relevant service, the timing and duration conditions for those factors, and the requirement that factors be related to the person's relevant service.

Definition of asthma: section 7(2) defines asthma as a chronic disorder of the airways characterised by variable and recurring symptoms, variable airflow obstruction, bronchial hyperresponsiveness and underlying inflammation, and explicitly includes reactive airways dysfunction syndrome. The Schedule expands reactive airways dysfunction syndrome into a six‑part clinical definition, including absence of pre‑existing asthma, single high‑concentration exposure, onset within 24 hours, persistence for at least three months, airflow limitation or bronchial hyperresponsiveness, and exclusion of other pulmonary disorders.

Death from asthma is included where death was contributed to by the person’s asthma, with 'terminal event' defined in the Schedule and examples given (pneumonia, respiratory failure, cardiac arrest, circulatory failure, cessation of brain function) (s 7(3), Schedule).

Causation framework: the RMA states its view that, on the sound medical‑scientific evidence available, it is more probable than not that asthma and death from asthma can be related to relevant service (s 8). The SoP operationalises that view by listing the factors that must exist; at least one of the listed factors must be present to support a balance‑of‑probabilities connection between asthma (or death from asthma) and the circumstances of relevant service (s 9).

Factors: section 9 enumerates factors that can establish causation. They include acute exposure to an immunologic/non‑immunologic stimulus within 24 hours of clinical onset (s 9(1)); prior sensitising exposure to an allergen (s 9(1A)); reactive airways from a single very high concentration irritant exposure (s 9(2)); being overweight or obese for five or more years prior to onset or worsening (ss 9(3), 9(7)); specified drug intake within 24 hours of onset or worsening (ss 9(4), 9(8)); smoking history at least equal to one pack‑year with defined cessation windows (ss 9(5), 9(9)); quantitative second‑hand smoke exposure of at least 1,000 hours in one year before clinical worsening (s 9(10)); clinically significant depressive disorder of six months duration before clinical worsening (s 9(11)); gastro‑oesophageal reflux disease at the time of clinical worsening (s 9(12)); and inability to obtain appropriate clinical management for asthma (s 9(13)).

Relativity to service: each factor must be related to the person's relevant service as defined in the Schedule, which includes eligible war service, defence service, and peacetime service under the MRCA (s 10(1), Schedule). Subsection 10(2) limits certain factors (ss 9(6)-9(13)) to claims of material contribution or aggravation where the asthma pre‑existed or was suffered or contracted prior to or during service but did not arise out of service.

Linkage to other SoPs: section 11 prescribes that if a factor refers to an injury or disease that is covered by another SoP, then the factors in that other SoP apply according to its terms.

Quantitative and definitional anchors: the Schedule fixes BMI as weight divided by height squared, defines overweight/obese as BMI 25 or greater, and defines one pack‑year as 20 cigarettes per day for one year or an equivalent conversion to tobacco weight, with a worked example and conversion to grams. It also lists example irritant substances associated with reactive airways dysfunction syndrome.

Together, these concepts create a predictable grid of temporality, exposure level and medical criteria that decision‑makers must test against evidence when assessing claims under the VEA and MRCA.

Primary affected parties are persons claiming entitlements under the Veterans' Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004 where asthma or death from asthma is at issue, because the instrument applies specifically to claims to which section 120B of the VEA or section 339 of the MRCA applies (s 5). Those claimants will include former members of the Forces and, in the case of death from asthma, dependants or representatives pursuing a related claim.

Decision-makers within the veterans' entitlement system are the immediate administrative users of the SoP. The instrument is made by the Repatriation Medical Authority under s 196B(3) of the VEA (s 3), and the RMA's stated medical‑scientific view (s 8) is the basis for the listed factors. While the instrument does not specify the administrative body that applies it, the VEA and MRCA referral points named in s 5 indicate that the instrument will be used by the agencies and tribunal processes that determine entitlements under those Acts.

Medical practitioners and medico‑legal advisers will be affected in their evidentiary role. The SoP prescribes precise clinical, temporal and quantitative elements that clinicians and forensic experts must address in reports. For example, practitioners will need to record whether reactive airways dysfunction syndrome criteria are met within 24 hours of exposure and persisted for at least three months (Schedule), whether a drug from the specified list was taken within 24 hours of onset or worsening (ss 9(4), 9(8); Schedule), and whether BMI reached 25 or greater for a five‑year period before onset or worsening (ss 9(3), 9(7); Schedule).

Employers, insurers and compensation professionals may be indirectly affected. The SoP changes how causation is established administratively for veterans' claims; changes in outcomes can affect the Commonwealth's liability and expenditure on medical and incapacity benefits. The SoP’s definitions and thresholds, such as the 1,000 hours threshold for second‑hand smoke in the year prior to clinical worsening (s 9(10)), will shape what evidence is collected and advanced, affecting litigation and settlement strategies.

Finally, family members or representatives pursuing death benefits will need to establish that a terminal event contributing to death falls within the Schedule's definition of terminal event and that asthma contributed to that terminal event (s 7(3); Schedule). Overall, the instrument reconfigures evidentiary requirements for a defined group of claimants and the professionals who prepare and decide their claims.

This SoP creates no new criminal or statutory duties, fines or private rights; rather, it specifies the medical‑factual conditions that must be established for an administrative causation finding in claims under the VEA and MRCA. Its legal effect operates through the entitlement statutes that require medical causation determinations, rather than by imposing direct obligations on individuals.

Right to rely on the SoP: a claimant has the procedural right to have their claim assessed against the SoP where the claim falls within the application provisions: it applies to claims to which s 120B VEA or s 339 MRCA applies (s 5). Practically, this means that when a decision-maker is determining whether asthma or death from asthma is connected with relevant service on the balance of probabilities, the presence of at least one of the listed factors in s 9, together with a sufficient nexus to relevant service (s 10(1)), is what the RMA identifies as sufficient medical‑scientific grounds for finding a connection.

Duty to relate factors to relevant service: section 10(1) requires that the existence of any factor in section 9 must be related to the person's relevant service. That operates as an evidential and legal requirement. It is not enough to show that a factor existed; there must be evidence tying that factor to events, exposures or circumstances of the person's relevant service as defined in the Schedule.

Limitations on material contribution/aggravation factors: subsection 10(2) confines factors in ss 9(6)-9(13) to determinations of material contribution to, or aggravation of, pre‑existing asthma where asthma was suffered or contracted before or during, but did not arise out of, relevant service. Practically, this means that those listed factors cannot be used to establish initial causation arising out of service, and are limited to aggravation claims.

Interconnection with other SoPs: section 11 provides that if a factor in s 9 refers to an injury or disease that is covered by another SoP, then the factors in that other SoP apply in accordance with their terms. The practical consequence is that the SoP defers to other RMA SoPs when causation involves comorbid or antecedent conditions that are the subject of separate SoPs.

Evidentiary expectations: while the SoP does not prescribe precise evidentiary standards beyond the balance‑of‑probabilities test, the specificity of temporal windows and quantitative thresholds in the Schedule creates de facto duties on claimants and medical reporters to provide detailed historical, clinical and exposure evidence. For example, proving one pack‑year requires quantifying cigarettes per day and duration, and the Schedule provides a conversion to grams of smoking tobacco and equivalencies for pipe tobacco and cigars.

No punitive sanctions: the instrument contains no penalty provisions. Enforcement is procedural and administrative, via decision-making under the VEA and MRCA; the SoP acts as a determinative medical standard within those administrative processes.

The Statement of Principles is a determinative medical instrument; it does not create criminal offences, civil penalties, or professional disciplinary obligations. There are no penalty clauses within the instrument. Its enforcement mechanism is administrative: the SoP provides the medical framework that decision-makers use when determining causation for entitlements under the VEA and MRCA. The instrument is made under subsection 196B(3) of the VEA (s 3) and applies to claims to which s 120B of the VEA or s 339 of the MRCA applies (s 5). Those statutory provisions govern entitlement determination, appeal rights, and any consequential administrative enforcement processes, but those provisions are not reproduced in this instrument and are located in the principal Acts.

Operational enforcement therefore depends on the routines of the agencies and tribunals that process VEA/MRCA claims. When a claim for asthma or death from asthma is assessed, decision-makers will test the facts against the listed factors in section 9 and the requirement that any such factor be related to relevant service (s 10). A positive finding of a factor, with the required nexus to service, supports an administrative finding of causation on the balance of probabilities. Conversely, absence of any applicable factor or lack of nexus to service will support a finding that asthma is not connected with service.

The instrument itself does not set administrative review or merits review mechanisms. Any review or appeal pathways arise from the VEA and MRCA and their associated review and tribunal arrangements. The SoP makes no provision for enforcement actions against medical practitioners or third parties who provide evidence; rather, practitioners’ reports will be weighed against the SoP in the normal adjudicative process.

Because the SoP requires certain temporally precise and quantitative evidence (for example, exposure within 24 hours before onset, or 1,000 hours of second‑hand smoke in one year), decision-makers will need to assess the sufficiency of evidence tendered. The instrument therefore shifts the evidentiary enforcement burden onto claimants and their advisers to assemble verifiable records and on decision-makers to apply the SoP’s criteria accurately. Any disputes about how the SoP applies in particular cases will be resolved through the statutory decision-review mechanisms in the VEA and MRCA rather than through sanctions under this instrument.

This SoP sits within the VEA/MRCA statutory framework and is expressly made under and for operation in relation to those Acts (s 3, s 5). It functions as a medical standard the RMA provides to inform causation findings required by the VEA and MRCA. Consequently, its practical legal effect is contingent on the decision‑making processes and review mechanisms embedded in those principal Acts. The instrument itself does not amend the VEA or MRCA; it supplies medical determinations that are applied by administrators and tribunals when those Acts require a causation finding.

Section 11 creates a direct inter‑instrument relationship with other Statements of Principles. Where a factor listed in section 9 refers to an injury or disease covered by another SoP, that other SoP’s factors apply in accordance with the terms of that SoP as in force from time to time. This cross-reference mechanism ensures internal coherence across the RMA’s SoP suite by deferring to specialised SoPs for comorbid or antecedent conditions. Practitioners must therefore identify and apply relevant cross‑referenced SoPs when a factor invokes another disease.

The Schedule references definitions that are also statutory anchors. Relevant service, for example, is defined to include eligible war service, defence service, and peacetime service under the MRCA (Schedule). That links the SoP’s factual requirements to statutory categories of service in the principal Acts and may affect admissibility and the evidential approach where a claimant’s service falls at the margins of those statutory categories.

The SoP’s reliance on medical and temporal thresholds interacts with evidentiary rules in administrative law and with medical privacy and records regimes. Although the instrument does not specify evidence admissibility or disclosure rules, its requirements will make medical records, occupational records, service records, and witness statements important to satisfy the specified windows and thresholds. Any statutory obligations under the Archives Act, privacy laws, or the principal Acts to disclose or withhold records will shape how claimants can satisfy the SoP.

Endnotes show amendment provisions and references to the Legislation Act 2003, including notes that certain sections were repealed or replaced in line with that Act (Endnote 4). The instrumentation and amendment history confirm that the SoP is maintained as part of a larger statutory and legislative-instrument ecosystem, and decision-makers must apply the SoP as in force, mindful of subsequent amendments and any related changes in the principal Acts or in other SoPs.

Finally, the SoP does not operate in the criminal law or industrial law spheres directly, but situations where exposure occurred during employment or as a result of third‑party acts may intersect with workers’ compensation schemes or tort claims. Those intersections are not addressed in the instrument; practitioners should cross‑reference relevant employment, compensation and tort regimes to determine parallel obligations and remedies, recognising that the SoP is a specific administrative standard for veterans’ entitlements decisions.

The compiled instrument includes amendments up to the Amendment Statement of Principles concerning asthma (Balance of Probabilities) (No. 93 of 2022) and the Veterans' Entitlements (Statements of Principles,definition of "one pack-year") Amendment Determination 2022 (No. 94 of 2022), both registered 26 August 2022 and commencing 19 September 2022 (Endnote 3). The original instrument was registered 9 March 2021 and commenced 5 April 2021 (Endnote 3).

Endnote 4 records provision‑level amendment information. Notable amendments identified in the endnote table include:

• Subsection 9(1A) was added by No. 93 of 2022 (Endnote 4). That insertion introduced the separate factor of having a sensitising exposure to an allergen before the clinical onset of asthma, with sensitising exposure defined in the Schedule. This created an additional pathway to establish causation where an earlier asymptomatic sensitising exposure is followed by a symptomatic re‑exposure within 24 hours.

• The Schedule definition of sensitising exposure to an allergen was also added by No. 93 of 2022 (Endnote 4), aligning the text of the Schedule to the new subsection.

• The note to subsection 9(5) and the Schedule definition of one pack‑year were amended by No. 94 of 2022 (Endnote 4). The Schedule now defines one pack‑year as 20 cigarettes per day for a period of one year, or an equivalent amount of tobacco products, supplying a conversion to grams and worked examples. The amendment clarifies equivalence rules for pipe tobacco, cigars and combinations, and establishes that 1 gram of tobacco equals one cigarette for conversion purposes.

The compilation notes that the day of commencement of those Amendment Determinations was 19 September 2022, and those changes are incorporated in the compiled text as at the compilation date (Compilation No. 1, compilation date 19 September 2022). The endnotes further explain that some sections were repealed or modified in relation to the Legislation Act 2003, for example section 2 and section 4 references in the amendment history list indicate repeal by the LA s 48C/D process (Endnote 4 notes sections affected: "Section 2 rep LA s 48D; Section 4 rep LA s 48C").

Practitioners should note that the instrument is maintained as a compilation and that uncommenced amendments may exist on the Legislation Register. The endnotes explain that uncommenced amendments are not shown, and readers should consult the Register for any amendments that had not commenced by the compilation date. The amendment history demonstrates that the RMA updates SoPs to refine medical criteria and definitional conversions, and that particular attention has recently been given to allergen sensitisation and to precise measurement of smoking exposure.

The compiled instrument contains no case law citations, and the endnotes record no litigation history within the instrument itself. The SoP is an administrative medical determination rather than a statute that generates direct reportable judicial decisions in its text. The document does not list, refer to, or summarise any judicial or tribunal decisions that have interpreted or applied this particular Statement of Principles.

Because the instrument is applied in VEA and MRCA entitlement decisions, disputes about its application will arise before administrative review bodies and potentially in courts, but those proceedings, if any, are not recorded in this instrument. The Schedule and sections direct decision-makers to apply the SoP’s factors, but do not provide guidance on adjudicative deference, standards of review, or the process of judicial challenge. Consequently, there is no litigation history within the instrument to summarise, and any case law that interprets how these factors operate in practice must be sourced from decisions under the VEA and MRCA and from administrative tribunal and judicial records outside the compiled text.

Practitioners seeking precedential or interpretative guidance will therefore need to search tribunal and court databases for decisions where the Repatriation Medical Authority’s SoPs, particularly this asthma SoP, have been considered. The absence of cases named in the instrument itself should not be read as an absence of adjudicative engagement in practice; it merely reflects that this instrument is a determinative administrative instrument and that its interaction with appellate or judicial review processes occurs in separate bodies and records.

Several specific features of the instrument create practical traps for claimants, advising clinicians, and decision-makers. These are not normative critiques, but source‑grounded points where outcomes can turn on technicalities in the SoP text.

1. Temporal precision: multiple factors require exposures or drug-taking within 24 hours before clinical onset or clinical worsening (ss 9(1), 9(2), 9(4), 9(6), 9(8)). Claims that rely on less precise temporal evidence may fail to meet these conditions even where a causal relation seems medically plausible.

2. Definition of clinical onset and worsening: the Schedule defines clinical worsening in a multi‑element way, including persistent change from well controlled to poorly controlled asthma, increased treatment requirements, severe episodes causing status asthmaticus, cerebral hypoxia or death, or increased hospitalisation. Demonstrating a change that meets one of these elements may require longitudinal medical records. Conversely, a single exacerbation that does not meet these listed outcomes may not qualify as clinical worsening for the purposes of ss 9(6)-9(13).

3. Pack‑year calculations: the Schedule defines one pack‑year precisely and supplies an equivalence to grams of tobacco and to non‑cigarette tobacco types. For historical smokers who used varying tobacco products, these conversion rules are operative and may produce counterintuitive pack‑year totals. The Schedule treats 1 gram of tobacco as equal to one cigarette for conversions, which is a specific metric that will drive causation determinations using ss 9(5) and 9(9).

4. Smoking cessation windows differ for onset and worsening: s 9(5)(b) requires onset within five years of cessation for smoking to be a factor for clinical onset, whereas s 9(9)(b) requires clinical worsening to have occurred within six months of cessation for smoking to be a factor in worsening. These asymmetric windows can materially affect claims where smoking ceased years earlier.

5. Overweight/obesity duration: being overweight or obese must have existed for at least five years prior to clinical onset or clinical worsening (ss 9(3) and 9(7)), and the Schedule defines overweight/obese as BMI of 25 or greater. Retrospective BMI documentation over a five‑year period may be sparse, particularly for older veterans.

6. Second‑hand smoke quantification: s 9(10) requires at least 1,000 hours of second‑hand smoke exposure in the year before clinical worsening. Quantifying hours in an enclosed space is inherently evidentially challenging and may rely on contemporaneous workplace records or consistent witness evidence. The Schedule defines having been exposed to second‑hand smoke as inhaling smoke in an enclosed space, but does not give practical methods for proving the 1,000‑hour threshold.

7. Clinically significant depressive disorder metric: the Schedule defines clinically significant as sufficient to warrant ongoing management, which may involve regular visits, for example at least monthly, but expressly notes that actual management need not have occurred. This creates a doctrinally specific test that may allow claims where a disorder would have warranted ongoing management even if access was not actually obtained.

8. 'Inability to obtain appropriate clinical management': s 9(13) is a catch‑all that admits inability to obtain proper management as a factor. The instrument does not specify thresholds or standards for what counts as inability to obtain appropriate management, generating potential discretionary assessments.

9. Reactive airways dysfunction syndrome criteria are cumulative and strict: the Schedule requires absence of prior asthma, single high‑concentration exposure, onset within 24 hours and persistence for at least three months, together with objective physiological testing and exclusion of other pulmonary disorders. Failure to show any one of these elements will defeat a reactive airways dysfunction syndrome finding.

10. Requirement to relate factors to relevant service: even where a factor is demonstrated, s 10(1) requires that it be related to the person's relevant service. The instrument does not define what depth of causal link suffices beyond the requirement; practitioners must therefore gather service records and exposure evidence to demonstrate the nexus.

11. Cross‑SoP interactions: s 11 requires application of other SoPs where a factor references a disease covered by another SoP. Failure to identify and apply the correct cross-referenced SoP can lead to misapplication of criteria.

Each of these elements increases the evidentiary burden on claimants and their advisers and creates areas where administrative determinations can hinge on record quality, professional reports and careful reconstructions of exposure histories.

For legal advisers, clinicians, case managers and claimants preparing an asthma or death from asthma claim under the VEA or MRCA, compliance is about assembling targeted evidence that maps directly to the SoP’s elements and the requirement that any factor be related to relevant service (s 10(1)). Below are concrete steps grounded in the instrument’s text.

1. Establish the claim’s statutory fit: confirm that the claim falls within s 120B of the VEA or s 339 of the MRCA, because the SoP applies to claims to which those sections apply (s 5). Identify the claimant’s category of relevant service as defined in the Schedule, for example eligible war service, defence service or peacetime service.

2. Map the causal pathway: identify which factor(s) in section 9 the claimant will rely upon. Only one listed factor is necessary to satisfy the SoP’s threshold for a causation connection. Remember that ss 9(6)-9(13) are limited to material contribution or aggravation of pre‑existing asthma where asthma pre‑existed or was suffered or contracted before or during service but did not arise out of service (s 10(2)). Avoid mixing factors intended for onset with those limited to aggravation without establishing the appropriate legal theory.

3. Temporal and exposure evidence: for factors requiring exposure or drug intake within 24 hours of onset or worsening, gather contemporaneous records indicating timing. For reactive airways claims (s 9(2) and reactive airways dysfunction syndrome in the Schedule), document the single specific inhalational exposure, concentration/intensity, onset within 24 hours and persistence for at least three months, and obtain objective pulmonary function testing showing airflow limitation with bronchodilator response or nonspecific bronchial hyperresponsiveness, together with supporting exclusion of other pulmonary disorders.

4. Smoking history and pack‑years: quantify cigarette use precisely to calculate pack‑years using the Schedule’s formula and equivalences. If the claimant used pipe tobacco or cigars, apply the Schedule’s conversion where 1 gram of tobacco equals one cigarette. Document cessation dates to check the relevant windows: within five years of cessation for onset (s 9(5)(b)), and within six months for worsening (s 9(9)(b)).

5. BMI and obesity duration: collect height and weight records to calculate BMI values and demonstrate a BMI ≥25 sustained for at least five years before clinical onset or worsening (ss 9(3), 9(7); Schedule). If continuous records are not available, secure medical notes, service medical exams, or other contemporaneous records to reconstruct BMI history.

6. Second‑hand smoke quantification: for s 9(10), prepare employment or service rosters, duty locations, shift patterns and witness statements to establish exposure in enclosed spaces and to quantify hours, targeting evidence showing at least 1,000 hours of exposure in the relevant one‑year period.

7. Mental health and comorbidities: for s 9(11) and s 9(12), obtain psychiatric and medical records evidencing clinically significant depressive disorder for at least six months before worsening, and records confirming diagnoses of gastro‑oesophageal reflux disease at the time of clinical worsening. Note the Schedule’s definition of clinically significant, where actual treatment is not required if the condition would have warranted ongoing management.

8. Drug exposure: record detailed medication histories to show intake of beta‑blockers, NSAIDs or paracetamol within 24 hours before clinical onset or worsening (ss 9(4), 9(8); Schedule).

9. Inability to obtain clinical management: if relying on s 9(13), assemble evidence of attempts to access care, systemic barriers, service availability at the time, and correspondence or records showing denial or unavailability; the instrument leaves the standard of proof open, so contemporaneous evidence is critical.

10. Tie factors to service: for every factor, produce evidence linking the exposure or condition to the claimant’s relevant service, such as service medical records, duty logs, unit records, deployment histories and contemporaneous reports. Section 10(1) requires that factors be related to relevant service.

11. Cross‑SoP checks: where a factor refers to an injury or disease that is the subject of another SoP, identify and assemble evidence required by that other SoP and ensure the decision-maker is directed to apply that SoP under s 11.

12. Expert reports: commission medico‑legal reports that address each element of the relevant SoP provision explicitly. Reports should map facts to the SoP subsections and the Schedule definitions, for example addressing whether a history meets the Schedule’s reactive airways dysfunction syndrome cumulative criteria.

13. Documentation of death claims: for death from asthma rely on the Schedule’s definition of terminal event and supply death certificates, clinician explanations linking asthma to the terminal event(s), and any hospital records showing respiratory failure or related terminal events (s 7(3); Schedule).

14. Monitor amendments: the SoP has been amended since first registration, with changes in 2022 to add sensitising exposure and to clarify pack‑year definition (Endnotes 3 and 4). Confirm you are working with the SoP as in force on the date of decision, and consult the Legislation Register for any later amendments.

15. Prepare for evidential challenges: anticipate that decision-makers will scrutinise the temporal precision, quantitative thresholds and service nexus. Develop clear summaries that cross-reference SoP provisions with the evidentiary record, and where evidence is incomplete, explain gaps and seek corroboration.

By aligning evidence and expert reports precisely with the SoP’s language and the Schedule definitions, practitioners can reduce the risk of findings turning on definitional or temporal technicalities.